Medical network - on February 15, two votes upgrade new rules will speed up the drug circulation enterprise integration, source in the Concorde lock mark don't move again and mergers and acquisitions, industrial funds for a dense... Investment and financing events a week, is in our hands.
Keywords: in current source in China Great Wall, Concorde pharmaceutical, John Hancock, guizhou lark, sig medical treatment, "and science and technology, medicine, diving medical help
Silence is not original shape, investment the frequency of the party is the norm. With focus on investment and financing events this week.
Countries do hair no. 13 "heavy," drugs circulation reform and upgrade again. Involves two votes policy to strengthen, fully implementing is the trend of The Times. In the light of the "2018 national push" time node, or into the promotion of the year this year, there is no doubt that reversed transmission companies accelerate the pace of integration. Cross-regional merger and reorganization, cross ownership into dense event worth looking forward to, the strong stronger or a foregone conclusion.
Policy changes also bring a lot of investment opportunities. Along with the policy and implement into the dense phase, divide the whole medicine plates, medical services, innovative medicine, medical equipment and medicine circulation industries, this action is likely to bring about a lot of capital.
Source in the union, on the other hand, the suspension restart merger caused concern. Gene companies in the United States following the 2015 m&a OriGene blocked after a year, domestic precision medical source in leading enterprises union, determined overweight gene field layout, continuation of previous plans again, pushing "cell + gene" dual-core driver development strategy.
The following for the health sector this period (February 6-12) sorting collection of investment and financing information:
1, China Great Wall end set up shenzhou jack medical industrial investment fund
February 12 evening, China Great Wall's announcement said the company had in order to promote the development of medical business, and hospital PPP project won the bid for the company and implementation support, proposed the shenzhou jack health industry investment fund, but due to the cooperation agreement has been signed for a year, the fund has not been established, intends to terminate the framework cooperation agreement, no longer to set up the fund. In addition, the company is a wholly owned subsidiary shenzhou 1 million yuan will be its holdings of China Great Wall international investment funds 100% stake to China roughly.
2, source in the Concorde to acquire a proud American sharp gene
On February 10, on the evening of cell genetic engineering source in the Concorde's announcement of listed companies, proposed through the acquisition of Shanghai pride has a 100% stake, a wholly owned subsidiary to the United States proud sharp in genes.
The announcement is the continuation of acquisitions in 2016. That year in March, 2.4 billion announced plans to source in union purchase proud sharp gene genetic technology companies in the United States; Until December, because of the controlling shareholder are planning and related important matters of the company, may constitute the material assets reorganization and suspended. It is reported, aimed at promoting the suspended again proud sharp gene acquisition.
3, guizhou lark offered 20 million industry fund refs
On February 10th, guizhou lark, according to the announcement in order to speed up the expansion of medical service business, accelerate the project company miao medicine integration advancement, seek synergy targets, with the company for limited partners by its own funds 20 million yuan investment in chongqing kingburg medical and health services industry equity funds partnership (limited partnership).
4, sig pharmaceutical $1 billion industry fund
Sig pharmaceutical late on Feb. 9, according to the announcement the company will with its own capital subscribed capital contribution is less than 1 billion yuan, in the establishment of Kang Meijian cast (guangdong) big health industry fund (limited partnership), fund total scale of 5 billion yuan. Funds will invest mostly large health industry chain upstream and downstream target company or project, a comprehensive health industry accurate service system.
5, John Hancock fund of medical treatment and throw 638 million industry mergers and acquisitions
Released on February 9, constant kang medical "about to participate in the investment industry mergers and acquisitions fund beijing-fuzhou announcement of China mining, according to the company with its own capital of 63.8 million yuan, to participate in the investment of beijing-fuzhou out (taizhou) asset management center (limited partnership). Funds will mainly including but not limited to general hospital, hospital, medical detection and so on domestic and foreign medical service agencies, to increase acquisition target, idle funds can be used for bank deposits and to buy bank financing products.
6, ICU medical $900 million acquisition of Pfizer Hospira infusion pump business
On February 9th, ICU Medical announced a $900 million to complete the acquisition of Pfizer's business Hospira infusion pump. The transaction price of $1 billion from the previous month decreased obviously. ICU will offer of new shares or $3.2 million and $419.3 million and $275 million in cash, and another $225 million will be based on the performance of the confirm by the end of 2019. It is reported, Hospira infusion pump business includes injection pump, solution, disposable supplies, and other assets. Pfizer will hold a 16.6% stake in ICU medical treatment.
7, the $128 million B round and science and technology be focused on tumor individual genetic testing
On February 9, "and (Beijing) technology co., LTD. Has recently obtained B round 128 million yuan financing, led party of ginkgo biloba, and fang was right in the heart innovation capital, south wind valley venture, precision medical fund, thick jersey capital, etc.
Register data show that "science and technology was founded in November 2014, largely based on high-throughput sequencing technology platform, provide circulating tumor DNA testing, engaged in noninvasive individualized accurate diagnosis and treatment, with diagnosis of the tumor and tumor mutation load monitoring in the course of the disease. After become angel, science and technology won A south wind vc investment, and at the beginning of 2016 to obtain Yi Fuze led more than 2000 ten thousand yuan A round of funding.
8, the Dutch biopharmaceutical company Prexton B round of $31 million
Announced on February 8th, Prexton Therapeutics to complete 29 million euros ($31 million) of B round, by Forbion Capital Partners and Seroba Life Sciences led together, other participating institutions Merck Ventures, including the current investors Ysios Capital and Sunstone Capital.
It is reported, Prexton Therapeutics committed to the development and treatment of central nervous system (CNS) disease of new compound drug, is the new biological pharmaceutical enterprise.
9, the pharmacist to help complete the $110 million B round Loose grain capital and fosun led
February 7 news, pharmacists help announcement has been completed by the end of December 2016 2016 yuan B round, this round of financing by loose grain capital, fosun collar, with round before capital, ivy and other investors continue to vote. This round of financing is mainly used for the construction of the drug trade B2B platform, a wider range of market development, SaaS can assign terminal project development and advance, and the upstream and downstream ecological system construction more perfect.
It is understood that the pharmacist help was founded in January 2015, is a medicine third-party B2B platform, the company of affiliation for guangzhou speed information technology co., LTD. In April 2016, A pharmacist to help won A Shanghai fosun, ivy, with wei capital, and many other well-known VC of A round of funding, total funds of 71 million yuan.
Increased 10, diving medical 147 million German subsidiary Yuwell Germany
News, February 6, diving medical, issued the announcement on the German subsidiary capital, said it would with self-raised funds of figure doering city in Germany (Tuttlingen), a wholly owned subsidiary company of Yuwell Germany GmbH for capital increase, total capital of not more than 20 million euros (about 147 million yuan). After completion of the capital increase, Yuwell Germany GmbH with a registered capital of not more than 30 million euros.
Diving medical is the domestic medical device manufacturing enterprise, was founded in 1998, on April 18, 2008 listed on the shenzhen stock exchange, the main products are household health care series, medical breathing and oxygen series and medical clinical series. |
